Clinical Trials
17 trialsNCT04305470 2026-05-18
MEN-301
NX Development Corp
Phase 3 Completed
NCT06665724 2026-02-27
Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)
Universität Münster
Phase 1 Completed
NCT04738162 2025-12-10
Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors
Universität Münster
Phase 2 Completed
NCT05362409 2025-06-19
Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma
Alpheus Medical, Inc.
Phase 1 Completed
NCT04845919 2024-11-12
Sonic ALA
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Phase 2 Completed
NCT01128218 2023-11-30
A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors
Southern Illinois University
Phase 1/2 Completed
NCT01502280 2023-11-24
BALANCE
St. Joseph's Hospital and Medical Center, Phoenix
Phase 3 Completed
NCT04055688 2022-05-31
Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT02155452 2022-05-06
ALAglioma
Tata Memorial Hospital
Completed
NCT00752323 2021-09-17
Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma
Case Comprehensive Cancer Center
Phase 2 Completed
NCT01682811 2021-06-18
Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)
Medical College of Wisconsin
Phase 1 Completed
NCT00870779 2019-06-14
FGR
Dartmouth-Hitchcock Medical Center
Phase 1 Completed
NCT00961090 2019-04-12
Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Phase 2 Completed
NCT01310868 2017-10-05
Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma
University College, London
Phase 2 Completed
NCT02755142 2016-05-23
Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas
medac GmbH
Phase 1/2 Completed
NCT00241670 2012-04-26
Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid
medac GmbH
Phase 3 Completed
NCT00671710 2011-01-14
Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
Advocate Hospital System
Phase 1 Completed